Picture of Terns Pharmaceuticals logo

TERN — Terns Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapNeutral

Brief: Terns Announces Pricing Of Upsized $650 Million Public Offering At $40 Per Share

Dec 9 (Reuters) - Terns Pharmaceuticals Inc TERN.O:

TERNS ANNOUNCES PRICING OF UPSIZED $650 MILLION PUBLIC OFFERING

TERNS PHARMACEUTICALS INC - PRICES UPSIZED OFFERING OF 16,250,000 SHARES AT $40.00 EACH

Source text: ID:nGNX4bPcJt

Further company coverage: TERN.O

 ((Reuters.briefs@thomsonreuters.com;))

Recent news on Terns Pharmaceuticals

See all news